Quality of life in Japanese women with postmenopausal osteoporosis treated with raloxifene and vitamin D: post hoc analysis of a postmarketing study

References

• Orimo H, Hashimoto T, Sakata K, et al. Trends in the incidence of hip fracture in Japan, 1987–1997: the third nationwide survey. J Bone Miner Metab 2000;18:126-31
   PubMed Web of Science ®Google Scholar
• Yoshimura N, Muraki S, Oka H, et al. Cohort profile: research on Osteoarthritis/Osteoporosis Against Disability study. Int J Epidemiol 2010;39:988-95
   PubMed Web of Science ®Google Scholar
• Silverman SL, Piziak VK, Chen P, et al. Relationship of health related quality of life to prevalent and new or worsening back pain in postmenopausal women with osteoporosis. J Rheumatol 2005;32:2405-9
   PubMed Web of Science ®Google Scholar
• Andersen SJ. Osteoporosis in the older woman. Clin Obstet Gynecol 2007;50:752-66
   PubMed Web of Science ®Google Scholar
• Gallagher JC, Levine JP. Preventing osteoporosis in symptomatic postmenopausal women. Menopause 2011;18:109-18
   PubMed Web of Science ®Google Scholar
• Lewiecki EM. Current and emerging pharmacologic therapies for the management of postmenopausal osteoporosis. J Womens Health (Larchmt) 2009;18:1615-26
   PubMed Web of Science ®Google Scholar
• Orimo H, Nakamura T, Hosoi T, et al. Japanese 2011 guidelines for prevention and treatment of osteoporosis – executive summary. Arch Osteoporos 2012;7:3-20
   PubMedGoogle Scholar
• Nakamura T. The Japanese Guidelines for the Prevention and Treatment of Osteoporosis (2006 Edition) and its significance. Nippon Rinsho 2007;65(Suppl):29-34
   PubMedGoogle Scholar
• Yoh K, Tanaka K, Ishikawa A, et al. Health-related quality of life (HRQOL) in Japanese osteoporotic patients and its improvement by elcatonin treatment. J Bone Miner Metab 2005;23:167-73
   PubMed Web of Science ®Google Scholar
• Yoh K, Hamaya E, Urushihara H, et al. Quality of life in raloxifene-treated Japanese women with postmenopausal osteoporosis: a prospective, postmarketing observational study. Curr Med Res Opin 2012;28:1757-66
   PubMed Web of Science ®Google Scholar
• Kushida K, Fukunaga M, Kishimoto H, et al. A comparison of incidences of vertebral fracture in Japanese patients with involutional osteoporosis treated with risedronate and etidronate: a randomized, double-masked trial. J Bone Miner Metab 2004;22:469-78
   PubMed Web of Science ®Google Scholar
• Morii H, Ohashi Y, Taketani Y, et al. Effect of raloxifene on bone mineral density and biochemical markers of bone turnover in Japanese postmenopausal women with osteoporosis: results from a randomized placebo-controlled trial. Osteoporos Int 2003;14:793-800
   PubMed Web of Science ®Google Scholar
• Saito M, Marumo K, Soshi S, et al. Raloxifene ameliorates detrimental enzymatic and nonenzymatic collagen cross-links and bone strength in rabbits with hyperhomocysteinemia. Osteoporos Int 2010;21:655-66
   PubMed Web of Science ®Google Scholar
• Takada J, Miki T, Imanishi Y, et al. Effects of raloxifene treatment on the structural geometry of the proximal femur in Japanese women with osteoporosis. J Bone Miner Metab 2010;28:561-7
   PubMed Web of Science ®Google Scholar
• Cranney A, Adachi JD. Benefit–risk assessment of raloxifene in postmenopausal osteoporosis. Drug Saf 2005;28:721-30
   PubMed Web of Science ®Google Scholar
• Kanis JA, Johansson H, Oden A, et al. A meta-analysis of the efficacy of raloxifene on all clinical and vertebral fractures and its dependency on FRAX. Bone 2010;47:729-35
   PubMed Web of Science ®Google Scholar
• Delmas PD, Ensrud KE, Adachi JD, et al. Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial. J Clin Endocrinol Metab 2002;87:3609-17
   PubMed Web of Science ®Google Scholar
• Delmas PD, Genant HK, Crans GG, et al. Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial. Bone 2003;33:522-32
   PubMed Web of Science ®Google Scholar
• Ettinger B, Black DM, Mitlak BH, et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA 1999;282:637-45
   PubMed Web of Science ®Google Scholar
• Kanis JA, Johnell O, Black DM, et al. Effect of raloxifene on the risk of new vertebral fracture in postmenopausal women with osteopenia or osteoporosis: a reanalysis of the Multiple Outcomes of Raloxifene Evaluation trial. Bone 2003;33:293-300
   PubMed Web of Science ®Google Scholar
• Maricic M, Adachi JD, Sarkar S, et al. Early effects of raloxifene on clinical vertebral fractures at 12 months in postmenopausal women with osteoporosis. Arch Intern Med 2002;162:1140-3
   PubMed Web of Science ®Google Scholar
• Nakamura T, Liu JL, Morii H, et al. Effect of raloxifene on clinical fractures in Asian women with postmenopausal osteoporosis. J Bone Miner Metab 2006;24:414-18
   PubMed Web of Science ®Google Scholar
• Seeman E, Crans GG, Diez-Perez A, et al. Anti-vertebral fracture efficacy of raloxifene: a meta-analysis. Osteoporos Int 2006;17:313-16
   PubMed Web of Science ®Google Scholar
• Siris ES, Harris ST, Eastell R, et al. Skeletal effects of raloxifene after 8 years: results from the continuing outcomes relevant to Evista (CORE) study. J Bone Miner Res 2005;20:1514-24
   PubMed Web of Science ®Google Scholar
• Ringe JD, Muhlenbacher D, Beck H. Diagnosis and therapy of osteoporosis in medical practice in Germany – a survey of 5902 female patients with osteoporosis prior to and after raloxifene treatment. Osteologie 2003;12:23-30
   Google Scholar
• Ringe JD, Christodoulakos GE, Mellstrom D, et al. Patient compliance with alendronate, risedronate and raloxifene for the treatment of osteoporosis in postmenopausal women. Curr Med Res Opin 2007;23:2677-87
   PubMed Web of Science ®Google Scholar
• Fujita T, Fujii Y, Munezane H, et al. Analgesic effect of raloxifene on back and knee pain in postmenopausal women with osteoporosis and/or osteoarthritis. J Bone Miner Metab 2010;28:477-84
   PubMed Web of Science ®Google Scholar
• Scharla S, Oertel H, Helsberg K, et al. Skeletal pain in postmenopausal women with osteoporosis: prevalence and course during raloxifene treatment in a prospective observational study of 6 months duration. Curr Med Res Opin 2006;22:2393-402
   PubMed Web of Science ®Google Scholar
• Adami S, Giannini S, Bianchi G, et al. Vitamin D status and response to treatment in post-menopausal osteoporosis. Osteoporos Int 2009;20:239-44
   PubMed Web of Science ®Google Scholar
• Gorai I, Hattori S, Tanaka Y, et al. Alfacalcidol-supplemented raloxifene therapy has greater bone-sparing effect than raloxifene-alone therapy in postmenopausal Japanese women with osteoporosis or osteopenia. J Bone Miner Metab 2012;30:349-58
   PubMed Web of Science ®Google Scholar
• Lim SK, Kung AW, Sompongse S, et al. Vitamin D inadequacy in postmenopausal women in Eastern Asia. Curr Med Res Opin 2008;24:99-106
   PubMed Web of Science ®Google Scholar
• Ohta H, Uemura Y, Nakamura T, et al. Serum 25-hydroxyvitamin D level as an independent determinant of quality of life in osteoporosis with a high risk for fracture. Clin Ther 2014;36:225-35
   PubMed Web of Science ®Google Scholar
• Orimo H, Hayashi Y, Fukunaga M, et al. Diagnostic criteria for primary osteoporosis: Year 2000 revision. J Bone Miner Metab 2001;19:331-7
   PubMed Web of Science ®Google Scholar
• Ware JE, Kosinski M, Dewey JE, et al. How to Score and Interpret Single-Item Health Status Measures: A Manual for Users of the SF-8 Health Survey. Lincoln, RI: Quality Metric Inc., 2001
   Google Scholar
• Kumamoto K, Nakamura T, Suzuki T, et al. Validation of the Japanese Osteoporosis Quality of Life Questionnaire. J Bone Miner Metab 2010;28:1-7
   PubMed Web of Science ®Google Scholar
• Takahashi H. Assessment of health related quality of life in osteoporotic patients. Nippon Rinsho 2002;60(Suppl 3):479-84
   PubMedGoogle Scholar
• The EuroQol Group. EuroQol – a new facility for the measurement of health-related quality of life. Health Policy 1990;16:199-208
   PubMed Web of Science ®Google Scholar
• Carlsson AM. Assessment of chronic pain. I. Aspects of the reliability and validity of the visual analogue scale. Pain 1983;16:87-101
   PubMed Web of Science ®Google Scholar
• Ostelo RW, de Vet HC. Clinically important outcomes in low back pain. Best Pract Res Clin Rheumatol 2005;19:593-607
   PubMed Web of Science ®Google Scholar
• Basaran S, Guzel R, Coskun-Benlidayi I, et al. Vitamin D status: effects on quality of life in osteoporosis among Turkish women. Qual Life Res 2007;16:1491-9
   PubMed Web of Science ®Google Scholar
• Motsinger S, Lazovich D, MacLehose RF, et al. Vitamin D intake and mental health-related quality of life in older women: the Iowa Women’s Health Study. Maturitas 2012;71:267-73
   PubMed Web of Science ®Google Scholar
• The Clinician’s Guide to Prevention and Treatment of Osteoporosis. National Osteoporosis Foundation, 2014. Available at: http://nof.org/files/nof/public/content/file/344/upload/159.pdf [Last accessed 14 May 2014]
   Google Scholar
• Francis R, Aspray T, Fraser W, et al. Vitamin D and Bone Health: A Practical Clinical Guideline for Patient Management. National Osteoporosis Society, 2013. Available at: http://www.nos.org.uk/document.doc?id=1352 [Last accessed 14 May 2014]
   Google Scholar
• Stewart JW, Alekel DL, Ritland LM, et al. Serum 25-hydroxyvitamin D is related to indicators of overall physical fitness in healthy postmenopausal women. Menopause 2009;16:1093-101
   PubMed Web of Science ®Google Scholar
• Boye ND, Oudshoorn C, van der Velde N, et al. Vitamin D and physical performance in older men and women visiting the emergency department because of a fall: data from the improving medication prescribing to reduce risk of falls (IMPROveFALL) study. J Am Geriatr Soc 2013;61:1948-52
   PubMed Web of Science ®Google Scholar
• Janssen HC, Samson MM, Verhaar HJ. Vitamin D deficiency, muscle function, and falls in elderly people. Am J Clin Nutr 2002;75:611-15
   PubMed Web of Science ®Google Scholar
• Haegerstam GA. Pathophysiology of bone pain: a review. Acta Orthop Scand 2001;72:308-17
   PubMed Web of Science ®Google Scholar
• Treede RD. The physiology of bone pain. Osteologie 1999;4:195-200
   Google Scholar
• Nakamura K, Saito T, Oyama M, et al. Vitamin D sufficiency is associated with low incidence of limb and vertebral fractures in community-dwelling elderly Japanese women: the Muramatsu Study. Osteoporos Int 2011;22:97-103
   PubMed Web of Science ®Google Scholar
• Bischoff-Ferrari HA, Willett WC, Wong JB, et al. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 2005;293:2257-64
   PubMed Web of Science ®Google Scholar
• Barone A, Giusti A, Pioli G, et al. Secondary hyperparathyroidism due to hypovitaminosis D affects bone mineral density response to alendronate in elderly women with osteoporosis: a randomized controlled trial. J Am Geriatr Soc 2007;55:752-7
   PubMed Web of Science ®Google Scholar
• Geller JL, Hu B, Reed S, et al. Increase in bone mass after correction of vitamin D insufficiency in bisphosphonate-treated patients. Endocr Pract 2008;14:293-7
   PubMedGoogle Scholar
• Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 2001;22:477-501
   PubMed Web of Science ®Google Scholar
• Malabanan A, Veronikis IE, Holick MF. Redefining vitamin D insufficiency. Lancet 1998;351:805-6
   PubMed Web of Science ®Google Scholar
• NAM Society. The role of calcium in peri- and postmenopausal women: 2006 position statement of the North American Menopause Society. Menopause 2006;13:862-77, quiz 878-80
   PubMed Web of Science ®Google Scholar